These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30511551)

  • 1. Chelation therapy for secondary neonatal iron over load: Lessons learned from rhesus hemolytic disease.
    Khdair-Ahmad F; Aladily T; Khdair-Ahmad O; Badran EF
    Turk J Pediatr; 2018; 60(3):335-339. PubMed ID: 30511551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desferrioxamine treatment of iron overload secondary to RH isoimmunization and intrauterine transfusion in a newborn infant.
    Yalaz M; Bilgin BS; Köroğlu OA; Ay Y; Arıkan C; Sagol S; Akısü M; Kültürsay N
    Eur J Pediatr; 2011 Nov; 170(11):1457-60. PubMed ID: 21735053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful chelation therapy in a case of neonatal iron overload following intravascular intrauterine transfusion.
    Sreenan C; Idikio HA; Osiovich H
    J Perinatol; 2000 Dec; 20(8 Pt 1):509-12. PubMed ID: 11190591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of rhesus hemolytic disease with hemophagocytosis and severe iron overload due to multiple transfusions.
    Yilmaz S; Duman N; Ozer E; Kavas N; Oren H; Demircioğlu F; Kumral A; Ozkan H; Irken G; Ozer E
    J Pediatr Hematol Oncol; 2006 May; 28(5):290-2. PubMed ID: 16772878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of chronic hepatitis B by iron chelation therapy in a patient with iron overload: A case report.
    Zou DM; Rong DD; Zhao H; Su L; Sun WL
    Medicine (Baltimore); 2017 Dec; 96(52):e9566. PubMed ID: 29384977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal hepatitis and excessive hepatic iron deposition following intrauterine blood transfusion.
    Lasker MR; Eddleman K; Toor AH
    Am J Perinatol; 1995 Jan; 12(1):14-7. PubMed ID: 7710568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deferasirox for managing transfusional iron overload in people with sickle cell disease.
    Meerpohl JJ; Antes G; Rücker G; Fleeman N; Niemeyer C; Bassler D
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007477. PubMed ID: 20687088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
    El-Beshlawy A; Manz C; Naja M; Eltagui M; Tarabishi C; Youssry I; Sobh H; Hamdy M; Sharaf I; Mostafa A; Shaker O; Hoffbrand AV; Taher A
    Ann Hematol; 2008 Jul; 87(7):545-50. PubMed ID: 18351337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome.
    Smits-Wintjens VE; Rath ME; Lindenburg IT; Oepkes D; van Zwet EW; Walther FJ; Lopriore E
    Neonatology; 2012; 101(4):306-10. PubMed ID: 22354012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-Based Optimisation of Deferoxamine Chelation Therapy.
    Bellanti F; Del Vecchio GC; Putti MC; Cosmi C; Fotzi I; Bakshi SD; Danhof M; Della Pasqua O
    Pharm Res; 2016 Feb; 33(2):498-509. PubMed ID: 26555666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patients.
    Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):332-8. PubMed ID: 19814679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased fetal iron load in rhesus hemolytic disease.
    Aygun C; Tekinalp G; Gurgey A
    Pediatr Hematol Oncol; 2004 Jun; 21(4):329-33. PubMed ID: 15205095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term administration of high-dose deferoxamine 2 days per week in thalassemic patients.
    Hagège I; Becker A; Kerdaffrec T; Kanfer A; Girot R
    Eur J Haematol; 2001 Oct; 67(4):230-1. PubMed ID: 11860443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined deferiprone and deferoxamine chelation therapy on iron load indices in beta-thalassemia.
    Tsironi M; Assimakopoulos G; Polonofi K; Rigaki K; Aessopos A
    Hemoglobin; 2008; 32(1-2):29-34. PubMed ID: 18274980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of early start of iron chelation therapy with deferiprone in young children newly diagnosed with transfusion-dependent thalassemia: A randomized controlled trial.
    Elalfy MS; Adly A; Awad H; Tarif Salam M; Berdoukas V; Tricta F
    Am J Hematol; 2018 Feb; 93(2):262-268. PubMed ID: 29119631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of deferasirox and deferoxamine in clinical practice: an alternative scheme of chelation in thalassemia major patients.
    Cassinerio E; Orofino N; Roghi A; Duca L; Poggiali E; Fraquelli M; Zanaboni L; Cappellini MD
    Blood Cells Mol Dis; 2014 Sep; 53(3):164-7. PubMed ID: 24846580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
    Kalpatthi R; Peters B; Kane I; Holloman D; Rackoff E; Disco D; Jackson S; Laver JH; Abboud MR
    Pediatr Blood Cancer; 2010 Dec; 55(7):1338-42. PubMed ID: 20981690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined iron chelation therapy.
    Galanello R; Agus A; Campus S; Danjou F; Giardina PJ; Grady RW
    Ann N Y Acad Sci; 2010 Aug; 1202():79-86. PubMed ID: 20712777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.